FTC Places Conditions on Watson Pharmaceutical's Proposed Acquisition of Actavis
Date
The Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and...